Table 5 Percent excess risk in age-specific respiratory health outcomes associated with SO2 exposure at lag 0–2 (both for exposure as a continuous variable and for days with pollution levels above the air quality guideline value)
SO2 (per 10 μg/m3) | SO2 levels > 125 μg/m3 | |||||
|---|---|---|---|---|---|---|
% | 95% CI | % | 95% CI | |||
Anti-asthma medication (AMD) | ||||||
Children 0–17 | 1.48% | 0.61% | 2.35% | 20.2% | 7.8% | 32.6% |
Adults 18–65 | 0.86% | 0.20% | 1.53% | 11.3% | 1.8% | 20.9% |
Elderly > 65 | 0.90% | 0.14% | 1.67% | 9.8% | −1.4% | 20.9% |
Primary care MD visits (PCMD) | ||||||
Children 0–17 | 1.24% | 0.40% | 2.08% | 14.2% | 3.0% | 25.5% |
Adults 18–65 | 1.21% | 0.63% | 1.79% | 18.5% | 10.6% | 26.3% |
Elderly > 65 | 1.11% | 0.14% | 2.09% | 11.8% | −2.0% | 25.6% |
Hospital Emergency Department (HED) | ||||||
Children 0–17 | 1.22% | −0.62% | 3.10% | 7.0% | −18.7% | 32.7% |
Adults 18–65 | 0.52% | − 0.99% | 2.06% | 0.0% | −20.7% | 20.7% |
Elderly > 65 | 1.01% | −0.62% | 2.66% | 19.7% | −1.8% | 41.2% |